Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks

Prenatal Diagnosis

Volumn 31, Issue 1, 2011, Pages 75-83

  Beta, Jarek ^a,b   Akolekar, Ranjit ^a   Ventura, Walter ^a   Syngelaki, Argyro ^a,b   Nicolaides, Kypros H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; PAPP A; PlGF; Preterm delivery; Serum biochemistry; Uterine artery Doppler

Indexed keywords

ACTIVIN A; CHORIONIC GONADOTROPIN BETA SUBUNIT; DISINTEGRIN; GROWTH DIFFERENTIATION FACTOR 6; INHIBIN A; MACROPHAGE ELASTASE; METALLOPROTEINASE; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MEDICAL HISTORY; OBSTETRICS; PLACENTA FUNCTION; PLACENTA PERFUSION; PREMATURE LABOR; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; PRENATAL DIAGNOSIS; PULSATILE FLOW; UTERINE ARTERY;

EID: 78650848116     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2662     Document Type: Article

References (68)

1. Agarwal N, Suneja A, Arora S, Tandon OP, Sircar S. 2004. Role of uterine artery velocimetry using color-flow Doppler and electromyography of uterus in prediction of preterm labor. J Obstet Gynecol Res 30: 402-408.
2. Akolekar R, Etchegaray A, Zhou Y, Maiz N, Nicolaides KH. 2009a. Maternal serum activin A at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Fetal Diagn Ther 25: 322-327.
3. Akolekar R, Minekawa R, Veduta A, Romero XC, Nicolaides KH. 2009b. Maternal plasma inhibin A at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn 29: 753-760.
4. Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. 2009c. Maternal serum placental protein 13 at 11 to 13 weeks of gestation in preeclampsia. Prenat Diagn 29: 1103-1108.
5. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. 2011. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31(1): 66-74.
6. Akolekar R, Zaragoza E, Poon LCY, Pepes S, Nicolaides KH. 2008. Maternal serum placental growth factor (PlGF) at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol 32: 732-739.
7. Aliyu MH, Lynch O, Saidu R, Alio AP, Marty PJ, Salihu HM. 2010. Intrauterine exposure to tobacco and risk of medically indicated and spontaneous preterm birth. Am J Perinatol 27: 405-410.
8. Ananth CV, Getahun D, Peltier MR, Salihu HM, Vintzileos AM. 2006. Recurrence of spontaneous versus medically indicated preterm birth. Am J Obstet Gynecol 195: 643-650.
9. Arias F, Rodriguez L, Rayi SC, Kraus FT. 1993. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 168: 585-591.
10. Arias F, Victoria A, Cho K, Kraus F. 1997. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 89: 265-271.
11. Balchin I, Steer P. 2007. Race, prematurity and immaturity. Early Hum Dev 83: 749-754.
12. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. 2005. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 106: 181-189.
13. Blickstein I. 2006. Does assisted reproduction technology, per se, increase the risk of preterm birth? BJOG 113: 68-71.
14. Bryant AS, Worjoloh A, Caughey AB, Washington AE. 2010. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol 202: 335-343.
15. Celik E, To M, Gajewska K, Smith GC, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. 2008. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol 31: 549-554.
16. Centre for Maternal and Child Enquiries (CMACE). 2010. Perinatal Mortality 2008: United Kingdom. CMACE: London.
17. Chafetz I, Kuhnreich I, Sammar M, et al. 2007. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 197: 35.e1-35.e7.
18. Chaiworapongsa T, Romero R, Tarca A, et al. 2009. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med 22: 1122-1139.
19. Cnattingius S, Forman MR, Berendes HW, Isotalo L. 1992. Delayed childbearing and risk of adverse perinatal outcome. A population-based study. JAMA 268: 886-890.
20. Cobian-Sanchez F, Prefumo F, Bhide A, Thilaganathan B. 2004. Second-trimester uterine artery Doppler and spontaneous preterm delivery. Ultrasound Obstet Gynecol 24: 435-439.
21. Cowans NJ, Spencer K. 2007. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 27: 264-271.
22. Cowans NJ, Spencer K, Meiri H. 2008. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes. Prenat Diagn 28: 121-125.
23. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191: 1446-1451.
24. Dugoff L, Hobbins JC, Malone FD, et al., FASTER Trial Research Consortium. 2005. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106: 260-267.
25. Farina A, Lambert-Messerlian GM, Canick JA, et al. 2006. Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients. Prenat Diagn 26: 277-281.
26. Filicori M, Cognigni GE, Gamberini E, Troilo E, Parmegiani L, Bernardi S. 2005. Impact of medically assisted fertility on preterm birth. BJOG 112: 113-117.
27. Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. 2003. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188: 419-424.
28. Fonseca RB, Celik E, Parra M, Singh M, Nicolaides KH. 2007. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357: 462-469.
29. Fonseca E, Yu CK, Singh M, Papageorghiou AT, Nicolaides KH. 2006. Relationship between second-trimester uterine artery Doppler and spontaneous early preterm delivery. Ultrasound Obstet Gynecol 27: 301-305.
30. French JI, McGregor JA. 1996. The pathobiology of premature rupture of membranes. Semin Perinatol 20: 344-368.
31. Germain AM, Carvajal J, Sanchez M, Valenzuela GJ, Tsunekawa H, Chuaqui B. 1999. Preterm labor: placental pathology and clinical correlation. Obstet Gynecol 94: 284-289.
32. Goetzinger KR, Cahill AG, Macones GA, Odibo AO. 2010. Association of first-trimester low PAPP-A levels with preterm birth. Prenat Diagn 30: 309-313.
33. Goldenberg RL, Culhane JF, Iams JD, Romero R. 2008. Epidemiology and causes of preterm birth. Lancet 371: 75-84.
34. Greco E, Lange A, Ushakov F, Rodriguez Calvo J, Nicolaides KH. 2011. Prediction of spontaneous preterm delivery from endocervical length at 11-13 weeks. Prenatal Diagn 31(1): 84-89.
35. Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH. 1998. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 12: 312-317.
36. Huang T, Hoffman B, Meschino W, Kingdom J, Okun N. 2010. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn 30: 471-477.
37. Iams JD, Goldenberg RL, Meis PJ, et al. 1996. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 334: 567-572.
38. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008a. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
39. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. 2008b. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31: 493-502.
40. Keirse MJ, Rush RW, Anderson AB, Turnbull AC. 1978. Risk of pre-term delivery in patients with previous pre-term delivery and/or abortion. Br J Obstet Gynaecol 85: 81-85.
41. Kim YM, Bujold E, Chaiworapongsa T, et al. 2003. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 189: 1063-1069.
42. Kim YM, Chaiworapongsa T, Gomez R, et al. 2002. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 187: 1137-1142.
43. Krantz D, Goetzl L, Simpson JL, et al., First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. 2004. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191: 1452-1458.
44. Lain SJ, Algert CS, Tasevski V, Morris JM, Roberts CL. 2009. Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study. BMC Med Res Methodol 9: 48.
45. Mathews TJ, MacDorman MF. 2008. Infant mortality statistics from the 2005 period linked birth/infant death data set. N Vital Stat Rep 57: 1-32.
46. McManemy J, Cooke E, Amon E, Leet T. 2007. Recurrence risk for preterm delivery. Am J Obstet Gynecol 196: 571-576.
47. Meis PJ, Klebanoff M, Thom E, et al., National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. 2003. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348: 2379-2385.
48. Mercer BM, Goldenberg RL, Moawad AH, et al., National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. 1999. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. Am J Obstet Gynecol 181: 1216-1221.
49. Morssink LP, Kornman LH, Hallahan TW, et al. 1998. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 18: 147-152.
50. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107: 1265-1270.
51. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749.
52. Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH. 2008. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol 112: 1082-1090.
53. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23-33.
54. Robinson HP, Fleming JE. 1975. A critical evaluation of sonar 'crown rump length' measurements. BJOG 182: 702-710.
55. Saigal S, Doyle LW. 2008. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371: 261-269.
56. Shah NR, Bracken MB. 2000. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 182: 465-472.
57. She BQ, Chen SC, Lee FK, Cheong ML, Tsai MS. 2007. Low maternal serum levels of pregnancy-associated plasma protein-A during the first trimester are associated with subsequent preterm delivery with preterm premature rupture of membranes. Taiwan J Obstet Gynecol 46: 242-247.
58. Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F. 2007. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 109: 1316-1324.
59. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87: 1762-1767.
60. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH, Fetal Medicine Foundation First Trimester Screening Group. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
61. Soares SC, Fratelli N, Prefumo F, Bhide A, Thilaganathan B. 2007. First-trimester uterine artery Doppler and spontaneous preterm delivery. Ultrasound Obstet Gynecol 29: 146-149.
62. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH. 2008. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 31: 147-152.
63. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. 2005. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 25: 949-953.
64. Strigini FA, Lencioni G, De Luca G, Lombardo M, Bianchi F, Genazzani AR. 1995. Uterine artery velocimetry and spontaneous preterm delivery. Obstet Gynecol 85: 374-377.
65. To MS, Skentou CA, Royston P, Yu CK, Nicolaides KH. 2006. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 27: 362-367.
66. Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z. 2003. Predicting complications of pregnancy with first-trimester maternal serum free-beta HCG, PAPP-A and inhibin-A. Prenat Diagn 23: 990-996.
67. Wang YA, Sullivan EA, Black D, Dean J, Bryant J, Chapman M. 2005. Preterm birth and low birth weight after assisted reproductive technology related pregnancy in Australia between 1996 and 2000. Fertil Steril 83: 1650-1658.
68. Zhang X, Cnattingius S, Platt RW, Joseph KS, Kramer M. 2007. Are babies born to short, primiparous, or thin mothers 'normally' or 'abnormally' small? J Pediatr 150: 607.e1-607.e3.